Volume 18, 2014

Sign On

Volume 18, 2014 CD
Six back issues from 2014 on one convenient CD.

Permanent storage and easy retrieval of IJPC articles and formulations.

Print journal articles in color from the PDF file for your marketing needs.
Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $95 per CD

This CD contains the following articles listed by volume, issue and page number:


Issues Included
Volume/Issue	Date	Title
Vol. 18 No. 1	January/February 2014	Volume 18, Number 1
Vol. 18 No. 2	March/April 2014	Volume 18, Number 2
Vol. 18 No. 3	May/June 2014	Volume 18, Number 3
Vol. 18 No. 4	July/August 2014	Volume 18, Number 4
Vol. 18 No. 5	September/October 2014	Volume 18, Number 5
Vol. 18 No. 6	November/December 2014	Volume 18, Number 6

Volume 18, 2014 CD ARTICLES

Title (Click for Details)	Vol/Issue	Page

Volume 18, 2014 CD ARTICLES
PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year	Vol. 18 No. 1	4
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013	Vol. 18 No. 1	6
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report	Vol. 18 No. 1	14
Good Enough for America	Vol. 18 No. 1	20
Determination of Risk for Sterile Preparations	Vol. 18 No. 1	30
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013	Vol. 18 No. 1	35
Marketing	Vol. 18 No. 1	38
Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks	Vol. 18 No. 1	42
Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding	Vol. 18 No. 1	46
Basics of Sterile Compounding: Bubble Point Testing	Vol. 18 No. 1	54
Calculations	Vol. 18 No. 1	58
Aztreonam Injection	Vol. 18 No. 1	60
Bumetanide 0.25-mg/mL Injection	Vol. 18 No. 1	61
Droperidol 2.5-mg/mL Injection	Vol. 18 No. 1	62
Lomustine 100-mg Capsules	Vol. 18 No. 1	63
Neostigmine Bromide 15-mg Capsules	Vol. 18 No. 1	64
Nimodipine 30-mg Capsules	Vol. 18 No. 1	65
Phenobarbital 60-mg Capsules	Vol. 18 No. 1	66
Potassium Chloride 2-mEq/mL Injection	Vol. 18 No. 1	67
Procainamide Hydrochloride 100-mg/mL Injection	Vol. 18 No. 1	68
Vasopressin 20-units/mL Injection	Vol. 18 No. 1	69
The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study	Vol. 18 No. 1	70
Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C	Vol. 18 No. 1	78
E-Prescribing Errors Identified in a Compounding Pharmacy: A Quality-improvement Project	Vol. 18 No. 1	83
PostScription: Pharmacy Benefit Managers and Compounding Pharmacists: Billing for Services	Vol. 18 No. 1	87
PreScription: Standards vs Opinions	Vol. 18 No. 2	92
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards	Vol. 18 No. 2	94
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective	Vol. 18 No. 2	101
Compounding Practices in Iran	Vol. 18 No. 2	112
IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities	Vol. 18 No. 2	117
Effective Advertisements	Vol. 18 No. 2	120
Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding	Vol. 18 No. 2	123
Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume	Vol. 18 No. 2	131
Basics of Compounding: Tips and Hints, Part 2: Compounding with Solutions, Suspensions, Emulsions, and Lotions	Vol. 18 No. 2	137
Calculations	Vol. 18 No. 2	140
Doxazosin 1-mg, 2-mg, 4-mg, or 8-mg Capsules	Vol. 18 No. 2	142
Fludarabine Phosphate 25-mg/mL Injection	Vol. 18 No. 2	143
Mecasermin 10-mg/mL Injection	Vol. 18 No. 2	144
Methylprednisolone 40-mg/mL Injection	Vol. 18 No. 2	145
Polymixin B Injection	Vol. 18 No. 2	146
Rocuronium Bromide 10-mg/mL Injection	Vol. 18 No. 2	147
Secretin 4 mcg/mL Injection	Vol. 18 No. 2	148
Selenium 40-mcg/mL Injection	Vol. 18 No. 2	149
Sincalide 1-mcg/mL Injection	Vol. 18 No. 2	150
Testosterone Enanthate 200-mg/mL Injection	Vol. 18 No. 2	151
Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride	Vol. 18 No. 2	152
E-Prescription Errors and Their Resolution in a Community Compounding Pharmacy	Vol. 18 No. 2	159
The Standardization of Nonsterile Compounding: A Study in Quality Control and Assessment for Hormone Compounding	Vol. 18 No. 2	162
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets	Vol. 18 No. 2	169
Recharting Your Vision While Remaining True to Your Charter	Vol. 18 No. 2	175
PreScription: Déjà Vu All Over Again	Vol. 18 No. 3	180
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications	Vol. 18 No. 3	182
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice	Vol. 18 No. 3	190
Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation	Vol. 18 No. 3	203
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter	Vol. 18 No. 3	208
Marketing: Effective Use of Advertisements on Your Website	Vol. 18 No. 3	210
Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1	Vol. 18 No. 3	213
Quality Control Analytical Methods: Establishing Powder-handling Workflow Practices and Standard Operating Procedures: Compounding Pharmacy and Safety	Vol. 18 No. 3	222
Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams	Vol. 18 No. 3	228
Calculations	Vol. 18 No. 3	231
Atorvastatin 10-mg or 20-mg Capsules	Vol. 18 No. 3	232
Bumetanide 0.5-mg, 1-mg, or 2-mg Capsules	Vol. 18 No. 3	233
Bupivacaine Hydrochloride 0.5% Injection	Vol. 18 No. 3	234
Butorphanol Tartrate 10-mg/mL Nasal Spray	Vol. 18 No. 3	235
Dibucaine 1% Ointment	Vol. 18 No. 3	236
Lidocaine Hydrochloride 1% Injection	Vol. 18 No. 3	237
Methotrexate 2.5-mg Capsules	Vol. 18 No. 3	238
Naproxen 25-mg/mL Oral Suspension	Vol. 18 No. 3	239
Tamoxifen 10-mg or 20-mg Capsules	Vol. 18 No. 3	240
Thiothixene 1-mg, 2-mg, 5-mg, or 10-mg Capsules	Vol. 18 No. 3	241
Examination of the Order of Incubation for the Recovery of Bacteria and Fungi from Pharmaceutical-grade Cleanrooms	Vol. 18 No. 3	242
Investigation of Physical and Chemical Stability of an Ointment with Herbals	Vol. 18 No. 3	248
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date	Vol. 18 No. 3	253
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery	Vol. 18 No. 3	256
PostScription: The Fourth Annual Student Pharmacist Compounding Competition: Building Future Leaders in the Industry	Vol. 18 No. 3	262
PreScription: Challenging Times	Vol. 18 No. 4	268
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety	Vol. 18 No. 4	270
Compounded Pain Formulations: What is the Evidence?	Vol. 18 No. 4	278
Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis	Vol. 18 No. 4	287
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India	Vol. 18 No. 4	293
400 Attendees Convene in Washington, D.C., for the 20th Annual Compounders on Capitol Hill	Vol. 18 No. 4	302
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2	Vol. 18 No. 4	305
Basics of Compounding Sterile Preparations: Nomenclature and Considerations	Vol. 18 No. 4	313
Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging	Vol. 18 No. 4	318
Calculations	Vol. 18 No. 4	320
Atracurium Besylate 10-mg/mL Injection, Preserved	Vol. 18 No. 4	322
Barium Sulfate Suspension	Vol. 18 No. 4	323
Calcitriol 1-mcg/mL Injection	Vol. 18 No. 4	324
Chloramphenicol 100-mg/mL Injection	Vol. 18 No. 4	325
Chlorothiazide 50-mg/mL Oral Suspension	Vol. 18 No. 4	326
Choline Magnesium Trisalicylate Liquid	Vol. 18 No. 4	327
Denileukin Diftitox 150-mcg/mL Injection	Vol. 18 No. 4	328
Indigo Carmine Injection	Vol. 18 No. 4	329
Propranolol Hydrochloride 1-mg/mL Injection	Vol. 18 No. 4	330
Zinc 1-mg/mL Injection	Vol. 18 No. 4	331
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream	Vol. 18 No. 4	332
Assessing the Use of Food Coloring as an Appropriate Visual Guide for Homogenously Mixed Capsule Powders in Extemporaneous Compounding	Vol. 18 No. 4	341
Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date	Vol. 18 No. 4	345
Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date	Vol. 18 No. 4	348
PostScription: Responsibilities of a Compounding Pharmacist	Vol. 18 No. 4	351
PreScription: What is a Compounding Pharmacist?	Vol. 18 No. 5	356
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy	Vol. 18 No. 5	358
To Compound or Not to Compound: A Veterinary Transdermal Discussion	Vol. 18 No. 5	366
Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report	Vol. 18 No. 5	370
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A	Vol. 18 No. 5	379
Health Care in Belarus in the 19th and 20th Centuries	Vol. 18 No. 5	382
Compounding Practices in a Portuguese Community Pharmacy	Vol. 18 No. 5	392
Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know	Vol. 18 No. 5	397
Basics of Compounding: Tips and Hints, Part 5: Facilities and Equipment	Vol. 18 No. 5	401
Marketing: Tips on Dealing With a Healthcare Practititioner's No-Rep Policy	Vol. 18 No. 5	406
Calculations	Vol. 18 No. 5	407
Azithromycin 100-mg/mL Injection	Vol. 18 No. 5	408
Bacitracin Topical Ointment	Vol. 18 No. 5	409
Dexpanthenol 250-mg/mL Injection	Vol. 18 No. 5	410
Ephedrine Sulfate 50-mg/mL Injection	Vol. 18 No. 5	411
Fluorescein 100-mg/mL Injection	Vol. 18 No. 5	412
Indocyanine green 2.5-mg/mL Injection	Vol. 18 No. 5	413
Phenylephrine Hydrochloride 2.5%-Ophthalmic Solution	Vol. 18 No. 5	414
Sulfamethoxazole and Trimethoprim Oral Solution	Vol. 18 No. 5	415
Sumatriptan Succinate 12-mg/mL Injection	Vol. 18 No. 5	416
Tranexamic Acid 100-mg/mL Injection	Vol. 18 No. 5	417
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation	Vol. 18 No. 5	418
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition	Vol. 18 No. 5	427
Stability of Tranexamic Acid in 0.9% Sodium Chloride, Stored in Type 1 Glass Vials and Ethylene/Propylene Copolymer Plastic Containers	Vol. 18 No. 5	432
PostScription: The Future of Veterinary Compounding	Vol. 18 No. 5	438
PreScription: "Named Formulas" Database Available	Vol. 18 No. 6	444
Depyrogenation Options for the Compounding Cleanroom	Vol. 18 No. 6	446
Standards of Practice, Professional Judgment, and Scientific Evidence to Establish and Extend a Beyond-Use Date	Vol. 18 No. 6	456
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Medications in a Rural Setting: A Case Study from the Delmarva Peninsula	Vol. 18 No. 6	462
Compounding Legislation: Focus Shifts to States	Vol. 18 No. 6	470
Quality Control: Can Compounding Pharmacy Learn from the Automotive Industry?	Vol. 18 No. 6	475
Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms	Vol. 18 No. 6	479
Basics of Compounding: Tips and Hints, Part 6: Prescription Evaluation, Calculations, Ingredients, Quality-Assurance Practices, Patient Counseling, Shipping and Distribution, Miscellaneous	Vol. 18 No. 6	486
Marketing: Using Facebook to Market Your Compounding Pharmacy	Vol. 18 No. 6	490
Calculations	Vol. 18 No. 6	492
Clarithromycin 250-mg or 500-mg Capsules	Vol. 18 No. 6	494
Dexmedetomidine 100 mcg/mL Injection	Vol. 18 No. 6	495
Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules	Vol. 18 No. 6	496
Leucovorin 10-mg/mL Injection	Vol. 18 No. 6	497
Levocarnitine 200-mg/mL Injection	Vol. 18 No. 6	498
Methazolamide 25-mg or 50-mg Capsules	Vol. 18 No. 6	499
Methylene Blue 10-mg/mL Injection	Vol. 18 No. 6	500
Methylphenidate Hydrochloride 10-mg Capsules	Vol. 18 No. 6	501
Oxacillin Sodium 167-mg/mL Injection	Vol. 18 No. 6	502
Tamsulosin Hydrochloride 0.2-mg Capsules	Vol. 18 No. 6	503
Skin Penetration and Antinociception of Topical Gabapentin Formulations	Vol. 18 No. 6	504
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations	Vol. 18 No. 6	512
Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils	Vol. 18 No. 6	516
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products	Vol. 18 No. 6	520
PostScription: Pharmacy Compounding Accreditation Board: Past, Present, and Future	Vol. 18 No. 6	526